Kendle's global footprint offers you more than just global reach. In addition to on-the-ground knowledge and understanding in any geography, we provide access to important patient populations. We have the infrastructure to support and deliver the largest Phase III megatrials, drawing on regulatory insights and operational efficiencies to create synergies across multiple-study programs.
“We are the only CRO to have been ranked consistently among the top two providers in the 2009, 2008 and 2007 CenterWatch Surveys of U.S. and European Investigative Sites.” *
Read more about our late stage expertise
Read more about our late stage locations
* Industry Standard Research. The “2009 CRO Benchmarking Report,” Cary, NC, USA, March 2009.